Filing Details
AIM ImmunoTech Inc. (AMEX:AIM) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event.
8k filedAMEX:AIM
AIM ImmunoTech Inc. (AIM) Reports Material Event to SEC
Filing Details AIM ImmunoTech Inc. (AMEX:AIM) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event. Market Context AIM…
Market Context
AIM ImmunoTech Inc.'s stock currently trades at $0.28 with a market capitalization of $3.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for AIM ImmunoTech Inc.'s stock.
All SEC filings for AIM ImmunoTech Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AIM Stock Page
Frequently Asked Questions
Where can I read AIM's SEC filings?
Browse all filings on our AIM SEC filings page.
What types of SEC filings does AIM ImmunoTech Inc. file?
Public companies like AIM ImmunoTech Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.